transthyretin | oneAMYLOIDOSISvoice

Oct 24, 2023

PLAIN LANGUAGE SUMMARY: From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial amyloid polyneuropathy

Aug 27, 2023

Acoramidis Reduces All-Cause, Cardiovascular Mortality at 30 Months in ATTR-CM

The 30-month results of the phase 3 ATTRibute-CM trial provide the latest insight into the effects of acoramidis in people with transthyretin amyloid cardiomyopathy…

Jun 25, 2021

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Sep 22, 2020

Avoiding Misdiagnosis: Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Amyloidosis for the General Practitioner

Jul 06, 2020

Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review

Mar 14, 2019

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy

Mar 21, 2017

From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial amyloid polyneuropathy

Sep 19, 2016

Identification of Prognostic Markers in Transthyretin and AL Cardiac Amyloidosis

Sep 13, 2016

Liver Transplantation in Transthyretin Amyloidosis: Characteristics and Management Related to Kidney Disease

Orthotopic liver transplantation (LT) was implemented as the inaugural disease-modifying therapy for hereditary transthyretin (ATTR) amyloidosis, a systemic…

May 16, 2016

Transthyretin Cardiac Amyloidosis in Black Americans

Subscribe to